ImmunoPET imaging noninvasively pinpoints colitis inflammation
A novel PET imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease...
List view / Grid view
A novel PET imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease...
The U.S. Food and Drug Administration has approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta to help reduce the risk of infection during cancer treatment.
Once-daily oral pill could replace preoperative chemotherapy in patient population if validated in larger trials...
Scientists have developed a new way of seeing when heavy wound scars are forming and providing doctors with the chance to intervene...
Researchers have developed a new form of microscopy that allows them to observe the formation and evolution of cell membrane focal adhesions...
A test that analyses free-floating DNA in the blood may be able to detect early-stage lung cancer...
An antifungal medication, commonly prescribed for toenail infections, could help eliminate dormant cells within bowel tumours, according to new research...
PEAK SCIENTIFIC, the global leader in laboratory gas generation, has launched its latest innovation today at the 66th ASMS Conference in San Diego, CA...
Technique measuring the cccDNA marker may allow earlier detection of hepatocellular carcinoma in patients…
Researchers in the U.S. and Japan want to use radio frequency identification (RFID) chips keeping track of organoids...
People who take immunosuppressants are less likely to develop Parkinson's disease...
Kaiser announces that their analytical solutions for in situ bioprocess monitoring and control has been recognised with the 2017 Aspen Award for the Advancement of Upstream Bioprocessing...
MECO, a world leader in engineered water purification solutions, is honoured to be a part of our customers’ success in the annual ISPE Facility of the Year Awards...
Collaboration also includes strategic investment by Aptar Pharma; will add connectivity to drug-delivery routes to improve adherence and treatment outcomes...
An FDA-approved drug for lymphoma and leukaemia may also help treat the most common - and deadliest type of brain tumour...